vs
达尔科技（DIOD）与Embecta Corp.（EMBC）财务数据对比。点击上方公司名可切换其他公司
达尔科技的季度营收约是Embecta Corp.的1.5倍（$391.6M vs $261.2M），Embecta Corp.净利率更高（16.9% vs 2.6%，领先14.3%），达尔科技同比增速更快（15.4% vs -0.3%），Embecta Corp.自由现金流更多（$16.6M vs $12.4M），过去两年达尔科技的营收复合增速更高（13.9% vs -4.6%）
达尔科技是一家全球性半导体制造商，主营分立器件、模拟及混合信号半导体产品的设计、生产与销售，产品广泛应用于汽车、工业、消费电子、计算及通信基础设施等核心领域，服务全球各地客户。
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
DIOD vs EMBC — 直观对比
营收规模更大
DIOD
是对方的1.5倍
$261.2M
营收增速更快
DIOD
高出15.7%
-0.3%
净利率更高
EMBC
高出14.3%
2.6%
自由现金流更多
EMBC
多$4.2M
$12.4M
两年增速更快
DIOD
近两年复合增速
-4.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $391.6M | $261.2M |
| 净利润 | $10.2M | $44.1M |
| 毛利率 | 31.1% | 61.9% |
| 营业利润率 | 3.4% | 31.9% |
| 净利率 | 2.6% | 16.9% |
| 营收同比 | 15.4% | -0.3% |
| 净利润同比 | 23.8% | — |
| 每股收益（稀释后） | $0.23 | $0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DIODEMBC
| Q4 25 | $391.6M | $261.2M | ||
| Q3 25 | $392.2M | $264.0M | ||
| Q2 25 | $366.2M | $295.5M | ||
| Q1 25 | $332.1M | $259.0M | ||
| Q4 24 | $339.3M | $261.9M | ||
| Q3 24 | $350.1M | $286.1M | ||
| Q2 24 | $319.8M | $272.5M | ||
| Q1 24 | $302.0M | $287.2M |
净利润DIODEMBC
| Q4 25 | $10.2M | $44.1M | ||
| Q3 25 | $14.3M | $26.4M | ||
| Q2 25 | $46.1M | $45.5M | ||
| Q1 25 | $-4.4M | $23.5M | ||
| Q4 24 | $8.2M | $0 | ||
| Q3 24 | $13.7M | $14.6M | ||
| Q2 24 | $8.0M | $14.7M | ||
| Q1 24 | $14.0M | $28.9M |
毛利率DIODEMBC
| Q4 25 | 31.1% | 61.9% | ||
| Q3 25 | 30.7% | 60.0% | ||
| Q2 25 | 31.5% | 66.7% | ||
| Q1 25 | 31.5% | 63.4% | ||
| Q4 24 | 32.7% | 60.0% | ||
| Q3 24 | 33.7% | 60.7% | ||
| Q2 24 | 33.6% | 69.8% | ||
| Q1 24 | 33.0% | 64.6% |
营业利润率DIODEMBC
| Q4 25 | 3.4% | 31.9% | ||
| Q3 25 | 3.0% | 21.4% | ||
| Q2 25 | 2.6% | 31.8% | ||
| Q1 25 | 0.4% | 24.3% | ||
| Q4 24 | 3.5% | 11.0% | ||
| Q3 24 | 6.2% | 9.2% | ||
| Q2 24 | 1.2% | 20.5% | ||
| Q1 24 | 4.3% | 13.6% |
净利率DIODEMBC
| Q4 25 | 2.6% | 16.9% | ||
| Q3 25 | 3.6% | 10.0% | ||
| Q2 25 | 12.6% | 15.4% | ||
| Q1 25 | -1.3% | 9.1% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 3.9% | 5.1% | ||
| Q2 24 | 2.5% | 5.4% | ||
| Q1 24 | 4.6% | 10.1% |
每股收益（稀释后）DIODEMBC
| Q4 25 | $0.23 | $0.74 | ||
| Q3 25 | $0.31 | $0.44 | ||
| Q2 25 | $0.99 | $0.78 | ||
| Q1 25 | $-0.10 | $0.40 | ||
| Q4 24 | $0.18 | $0.00 | ||
| Q3 24 | $0.30 | $0.24 | ||
| Q2 24 | $0.17 | $0.25 | ||
| Q1 24 | $0.30 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $377.0M | $201.3M |
| 总债务越低越好 | $25.7M | — |
| 股东权益账面价值 | $1.9B | $-613.1M |
| 总资产 | $2.4B | $1.1B |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资DIODEMBC
| Q4 25 | $377.0M | $201.3M | ||
| Q3 25 | $386.4M | $225.5M | ||
| Q2 25 | $327.3M | $230.6M | ||
| Q1 25 | $343.9M | $209.3M | ||
| Q4 24 | $316.1M | $210.0M | ||
| Q3 24 | $319.3M | $267.5M | ||
| Q2 24 | $273.9M | $275.1M | ||
| Q1 24 | $276.0M | $299.8M |
总债务DIODEMBC
| Q4 25 | $25.7M | — | ||
| Q3 25 | $24.9M | $1.4B | ||
| Q2 25 | $26.4M | — | ||
| Q1 25 | $20.5M | — | ||
| Q4 24 | $20.7M | — | ||
| Q3 24 | $22.2M | $1.6B | ||
| Q2 24 | $20.3M | — | ||
| Q1 24 | $20.9M | — |
股东权益DIODEMBC
| Q4 25 | $1.9B | $-613.1M | ||
| Q3 25 | $1.9B | $-650.6M | ||
| Q2 25 | $1.9B | $-669.6M | ||
| Q1 25 | $1.8B | $-736.2M | ||
| Q4 24 | $1.8B | $-768.8M | ||
| Q3 24 | $1.8B | $-738.3M | ||
| Q2 24 | $1.8B | $-763.7M | ||
| Q1 24 | $1.7B | $-769.6M |
总资产DIODEMBC
| Q4 25 | $2.4B | $1.1B | ||
| Q3 25 | $2.5B | $1.1B | ||
| Q2 25 | $2.5B | $1.2B | ||
| Q1 25 | $2.4B | $1.1B | ||
| Q4 24 | $2.4B | $1.1B | ||
| Q3 24 | $2.4B | $1.3B | ||
| Q2 24 | $2.4B | $1.3B | ||
| Q1 24 | $2.4B | $1.2B |
负债/权益比DIODEMBC
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.01× | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.1M | $17.2M |
| 自由现金流经营现金流 - 资本支出 | $12.4M | $16.6M |
| 自由现金流率自由现金流/营收 | 3.2% | 6.4% |
| 资本支出强度资本支出/营收 | 6.6% | 0.2% |
| 现金转化率经营现金流/净利润 | 3.74× | 0.39× |
| 过去12个月自由现金流最近4个季度 | $137.2M | $205.8M |
8季度趋势，按日历期对齐
经营现金流DIODEMBC
| Q4 25 | $38.1M | $17.2M | ||
| Q3 25 | $79.1M | $84.0M | ||
| Q2 25 | $41.5M | $81.2M | ||
| Q1 25 | $56.7M | $31.8M | ||
| Q4 24 | $81.8M | $-5.3M | ||
| Q3 24 | $54.4M | $26.6M | ||
| Q2 24 | $14.4M | $-2.1M | ||
| Q1 24 | $-31.1M | $24.3M |
自由现金流DIODEMBC
| Q4 25 | $12.4M | $16.6M | ||
| Q3 25 | $62.8M | $76.7M | ||
| Q2 25 | $21.1M | $80.8M | ||
| Q1 25 | $40.8M | $31.7M | ||
| Q4 24 | $62.1M | $-6.8M | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-3.5M | $-11.8M | ||
| Q1 24 | $-51.5M | $20.9M |
自由现金流率DIODEMBC
| Q4 25 | 3.2% | 6.4% | ||
| Q3 25 | 16.0% | 29.1% | ||
| Q2 25 | 5.8% | 27.3% | ||
| Q1 25 | 12.3% | 12.2% | ||
| Q4 24 | 18.3% | -2.6% | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | -1.1% | -4.3% | ||
| Q1 24 | -17.1% | 7.3% |
资本支出强度DIODEMBC
| Q4 25 | 6.6% | 0.2% | ||
| Q3 25 | 4.2% | 2.8% | ||
| Q2 25 | 5.6% | 0.1% | ||
| Q1 25 | 4.8% | 0.0% | ||
| Q4 24 | 5.8% | 0.6% | ||
| Q3 24 | 4.3% | 0.0% | ||
| Q2 24 | 5.6% | 3.6% | ||
| Q1 24 | 6.7% | 1.2% |
现金转化率DIODEMBC
| Q4 25 | 3.74× | 0.39× | ||
| Q3 25 | 5.54× | 3.18× | ||
| Q2 25 | 0.90× | 1.78× | ||
| Q1 25 | — | 1.35× | ||
| Q4 24 | 9.93× | — | ||
| Q3 24 | 3.95× | 1.82× | ||
| Q2 24 | 1.80× | -0.14× | ||
| Q1 24 | -2.22× | 0.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
